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doi:10.1Objective: Previous studies have developed cardiovascular surgery outcome prediction models using only pa-
tient risk factors, but surgery outcomes from the patient’s perspective seem to differ between hospitals. We have
developed outcome prediction models that incorporate preoperative patient risks, as well as hospital processes
and structure.
Methods: Data were collected from the Japan Cardiovascular Database for patients scheduled for cardiovascu-
lar surgery between January 2005 and December 2007. We analyzed 33,821 procedures in 102 hospitals. Logis-
tic regression was used to generate risk models, which were then validated through split-sample validation.
Results: Odds ratios, 95% confidence intervals, and P values for structures and processes in the mortality pre-
diction model were as follows: ‘‘hospital annual adult cardiac surgery volume (continuous; every 1 procedure
increase per year)’’ (odds ratio, 0.998; confidence interval, 0.997–0.999; P<.001); ‘‘recommended staffing and
equipment’’ (odds ratio, 0.75; confidence interval, 0.64–0.87; P<.001); ‘‘daily conferences with cardiologists’’
(odds ratio, 0.79; confidence interval, 0.60–1.02; P¼ .073); ‘‘intensivists involved in postsurgical management’’
(odds ratio, 0.89; confidence interval, 0.77–1.02; P ¼ .90); ‘‘public hospitals’’ (odds ratio, 0.80; confidence
interval, 0.70–0.93; P ¼ .003); ‘‘surgeons lacking miscellaneous duties’’ (odds ratio, 0.80; confidence interval,
0.70–0.93; P ¼ .003); and ‘‘surgeons who work no more than 32 hours per week’’ (odds ratio, 0.55; confidence
interval, 0.32–0.95; P¼ .032). The mortality prediction model had a C-index of 0.85 and a Hosmer–Lemeshow
P value of .79.
Conclusions: Our models yielded good discrimination and calibration, so they may prove useful for hospital
selection based on individual patient risks and circumstances. Improved surgeon work environments were
also shown to be important for both surgeons and patients. (J Thorac Cardiovasc Surg 2011;142:e71-6)A
C
DPatient outcome evaluation is gaining acceptance as a first
step in the assessment and improvement of healthcare qual-
ity. Prior studies identified predictors of mortality and mor-
bidity,1-6 but many of these models were developed using
only patient risk factors. Given that most of these models
were created for healthcare quality benchmarking, their
predicted outcomes should not rely on the particular
hospital in which the procedure was performed. However,
from the patient’s perspective, predicted outcomes of
cardiovascular surgery seem to differ between hospitals,
a perception that has been proven accurate.
Many studies have suggested that patients undergoing
cardiovascular surgery at high-volume hospitals have lower
risks of operative mortality compared with patients at
lower-volume centers.7-11 Hospital volume is used as
a surrogate measure for numerous processes of care that
directly influence patient outcomes because individual
processes have not been well characterized and aree Japan Cardiovascular Surgery Database, Tokyo, Japan.
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The Journal of Thoracic and Cadifficult to measure. For some procedures, higher volume,
particularly at the surgeon level, may translate directly to
better clinical judgment and technical proficiency in the
operating room. Such processes may be hard to transfer to
lower-volume providers. On the other hand, high-volume
and low-volume centers may also differ with regard to other
processes of preoperative and postoperative care, which
could be adopted by lower-volume centers.12
To better understand the volume–outcome relationship in
cardiovascular surgery, we focused on practices that involve
cardiovascular procedures, including hospital processes and
structure, which embody potential risks of perioperative
mortality. These models may be useful not only for cardiol-
ogists considering treatment indication and referral but
also for patients, because they may assist patients in site
selection.MATERIALS AND METHODS
Study Population
The Japan Adult Cardiovascular Surgery Database (JACVSD) was
initiated in 2000 to estimate surgical outcomes after cardiovascular proce-
dures in many centers throughout Japan. The JACVSD adult cardiovascular
division currently captures clinical information from approximately half of
all Japanese hospitals performing cardiovascular surgery. The data collec-
tion form has 255 variables (definitions are available online at http://www.
jacvsd.umin.jp), and these are almost identical to those in the Society of
Thoracic Surgeons National Database (definitions are available online atrdiovascular Surgery c Volume 142, Number 3 e71
Abbreviations and Acronyms
CI ¼ confidence interval
JACVSD ¼ Japan Adult Cardiovascular Surgery
Database
OR ¼ odds ratio
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collection system through which the data manager of each participating
hospital submits their data electronically to the central office. Although
participation in the JACVSD is voluntary, data completeness is a high pri-
ority. Accuracy of submitted data was maintained by a data audit that was
achieved by monthly visits by administrative office members to the partici-
pating hospital to check data against clinical records. Validity of data was
further confirmed by an independent comparison of the volume of cardiac
surgery at a particular hospital entered in the JACVSDwith that reported in
the annual survey by the Japanese Association for Thoracic Surgery.13
We examined all cardiovascular surgery procedures between January 1,
2005, and December 31, 2007. JACVSD records that had been obtained
without patients’ informed consent were excluded from this analysis. Re-
cords with missing age (or out of range), sex, or 30-day status (see ‘‘End
Points’’) were also excluded. With the exception of body surface area,
sex-specific median values were entered for all missing or out-of-range
values. Although participation in the JACVSD is voluntary, data complete-
ness is high, and less than 3% entries lack overall preoperative risk factors
used in this study. After this data cleaning, the population for this risk
model analysis consisted of 33,821 cardiovascular procedures from 102
participating sites throughout Japan. On the basis of interviews with cardio-
vascular surgeons and former studies (references), we developed items re-
garding structures (resources and administration) and processes (culture
and professional cooperation) that may affect cardiovascular surgery
outcomes.
End Points
The primary outcome measure of the JACVSD was 30-day operative
mortality, which was defined exactly the same as the 30-day operative mor-
tality in the Society of Thoracic Surgeons National Database. This includes
any patient who died during the index hospitalization, regardless of the
length of hospital stay, and any patient who died within 30 days of the op-
eration after being discharged from the hospital. By using the definition
from a previous study,14,15 major morbidity was defined as any of the
following 5 postoperative in-hospital complications: stroke, reoperation
for any reason, need for mechanical ventilation for more than 24 hours after
surgery, renal failure, or deep sternal wound infection.
Statistical Analysis
Data (n ¼ 33,821) were randomly divided into 2 subsets for model de-
velopment (27,191 records, 80%) and validation tests (6630 records,
20%). The statistical model was multiple logistic regression; variables en-
tered in the model were selected from all variables shown in Tables 1 and 2
using bivariate tests. Chi-square tests analyzed categoric covariates, and
unpaired t tests or Wilcoxon rank-sum tests were used for continuous cova-
riates. All variables significant at the P< .2 level were entered into the
model. This model considered volume a continuous variable. A multivari-
ate stepwise logistic regression analysis was then performed for each out-
come. Stability of the model was checked every time a variable was
eliminated. When all statistically nonsignificant variables had been elimi-
nated from the model, ‘‘goodness-of-fit’’ was evaluated and the area under
the receiver operating characteristic curve was used to assess how well the
model could discriminate between patients who lived and patients who had
died.16 Model calibration (the degree to which observed outcomes weree72 The Journal of Thoracic and Cardiovascular Surgsimilar to the predicted outcomes across patient groups) was evaluated
by comparing the observed with the predicted mean values within each
of 10 equal-sized subgroups arranged in order of increasing patient risk.
To evaluate model calibration, the Hosmer–Lemeshow test was applied.RESULTS
Patient Characteristics
Patient characteristics and outcomes of each procedure
are shown in Table 1. The 33,821 procedures consisted of
the following: isolated CABG surgery (n ¼ 10,972), valve
surgery (n ¼ 10,935), thoracic aortic surgery (n ¼ 7559),
and other procedures (n ¼ 4355). Patient median age was
68.9 years (range 60.0–75.2 years), and the percentage of
male patients per procedure was as follows: CABG surgery
(77.2%), valve surgery (55.1%), thoracic aortic surgery
(64.5%), and other procedures (57.3%). As shown in
Table 3, 30-day operative mortality rates were 2.2% for iso-
lated CABG surgery, 3.7% for valve surgery, 8.4% for tho-
racic aortic surgery, and 7.1% for other procedures.
Composite rates for mortality or major morbidity were
14.2% for isolated CABG surgery, 15.5% for valve sur-
gery, 31.7% for thoracic aortic surgery, and 7.1% for other
procedures.Participant Hospital Characteristics
The characteristics of participant hospitals are shown in
Table 2. Of the 102 hospitals, 53.9% were public hospitals
(managed by a local public organization), 45.1% were uni-
versity hospitals (affiliated with a university), and 89.2%
were general hospitals (had various diagnosis and treatment
departments, including at least an internal medicine depart-
ment and a surgery department). Sixty-one (63.7%) of the
participating hospitals met staffing and equipment criteria
recommended by previous research in Japan of having
more than 4 cardiovascular surgeons, more than 2 expert
cardiovascular surgeons, more than 4 cardiologists, more
than 2 anesthesiologists, more than 2 clinical engineers,
an intensive-care unit facility, a hemodialysis unit, and
more than 2 heart-lung machines. Most participant hospitals
(97.1%) held more than 1 conference per week with cardio-
vascular surgeons.Model Results and Performance
Two models were developed, and the final logistic model
is presented in Table 4. Odds ratios (ORs), confidence inter-
vals (CIs), and P values for structures and processes in the
mortality prediction model were as follows: ‘‘hospital an-
nual adult cardiac surgery volume (continuous: every 1 pro-
cedure increase per year)’’ (OR, 0.998; CI, 0.997–0.999;
P< .001); ‘‘recommended staffing and equipment’’ (OR,
0.75; CI, 0.64–0.87; P<.001); ‘‘daily conferences with car-
diologists’’ (OR, 0.79; CI, 0.60–1.02; P¼ .073); ‘‘intensiv-
ists involved in postsurgical management’’ (OR, 0.89; CI,
0.77–1.02; P ¼ .90); ‘‘public hospitals’’ (OR, 0.80; CI,ery c September 2011
TABLE 1. Characteristics of patients (N ¼ 33,821)
All patients (n ¼ 33,821) Test data set (N ¼ 27,191) Validation data set (N ¼ 6630)
Age (y), median (25–75) 68.9 (60.0–75.2) 68.9 (60.0–75.2) 69.0 (59.8–75.3)
BSA (kg/m2) median (25–75) 1.60 (1.47–1.73) 1.60 (1.47–1.73) 1.60 (1.46–1.73)
n % n % n %
Gender (male) 21,909 64.8 17,575 64.6 4334 65.4
BMI 31–35 kg/m2 923 2.7 759 2.7 163 2.7
BMI>35 kg/m2 142 0.4 125 0.5 17 0.3
Smoking 13,886 41.1 11,134 40.9 2752 41.5
Diabetes 8778 26.0 7060 26.0 1718 25.9
Renal failure 3807 11.3 3080 11.3 727 11.0
Renal failure requiring dialysis 1682 5.0 1370 5.0 312 4.7
Cerebrovascular disease (recent) 340 1.0 268 1.0 72 1.1
Infectious endocarditis 705 2.1 549 2.0 156 2.4
COPD (moderate, severe) 671 2.0 551 2.0 120 1.8
Extracardiac arteriopathy (peripheral) 3398 10.0 2750 10.1 648 9.8
Extracardiac arteriopathy (thoracic) 5992 17.7 4842 17.8 1150 17.3
Neurologic disorder 1302 3.8 1055 3.9 247 3.7
Congestive heart failure 8193 24.2 6589 24.2 1604 24.2
Cardiogenic shock 1579 4.7 1269 4.7 310 4.7
NYHA IV 2951 8.7 2362 8.7 589 8.9
Preoperative inotropic agents 1676 5.0 1342 4.9 334 5.0
Triple vessel disease 9120 27.0 7343 27.0 1777 26.8
Poor LV function 1745 5.2 1397 5.1 348 5.2
Tricuspid stenosis 85 0.3 70 0.3 15 0.2
Reoperation 2126 6.3 1705 6.3 421 6.3
Status (urgent) 2772 8.2 2213 8.1 559 8.4
Status (emergency) 3480 10.3 2762 10.2 718 10.8
Surgery type ‘‘isolated CABG’’ (reference) 10,972 32.4 8804 32.4 2168 32.7
CABG combined surgery 3427 10.1 2783 10.0 699 10.5
Surgery type ‘‘valve’’ 10,935 32.3 8839 32.5 2096 31.6
Aortic valve plus mitral valve 1432 4.2 1138 4.2 294 4.4
Surgery type ‘‘thoracic aorta’’ 7559 22.4 6089 22.4 1470 22.2
Thoracic aortic surgery indication (rupture) 662 2.0 524 1.9 138 2.1
Range of replacement (root) 922 2.7 729 2.7 193 2.9
Range of replacement (arch) 3061 9.1 2470 9.1 591 8.9
Range of replacement (distal) 1288 3.8 1042 3.8 246 3.7
Range of replacement (descending) 1361 4.0 1114 4.1 247 3.7
Range of replacement (thoracoabdominal) 553 1.6 451 1.7 102 1.5
Surgery type ‘‘other procedures’’ 4355 12.9 3459 12.7 896 13.5
Resection/myoplasty 157 0.5 119 0.4 38 0.6
Septal perforation/rupture 314 0.9 255 0.9 59 0.9
BSA, Body surface area; BMI, body mass index; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association; LV, left ventricle; CABG, coronary artery
bypass grafting.
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D0.70–0.93; P ¼ .003); ‘‘surgeons who lack miscellaneous
duties’’ (OR, 0.80; CI, 0.70–0.93; P¼ .003); and ‘‘surgeons
who do not perform more than 32 hours of continuous la-
bor’’ (OR, 0.55; CI, 0.32–0.95; P ¼ .032).
Model performance was evaluated using the C-index
(area under the receiver operating characteristic curve) as
a measure of model discrimination and the Hosmer–
Lemeshow test as a measure of ‘‘goodness-of-fit.’’ The
C-index was 0.85 for the mortality model and 0.74 for the
composite mortality or morbidity model; the Hosmer–
Lemeshow test P value was .79 for the mortality modelThe Journal of Thoracic and Caand 0.49 for the composite mortality or morbidity model.
Details of model performance metrics are shown in Table 5.
DISCUSSION
In this study, we developed a cardiovascular surgery risk
prediction model from the patient perspective. Results of
the C-index and Hosmer–Lemeshow test indicate good dis-
crimination and calibration of the models. Patients may use
these models to select a hospital according to their individ-
ual risks and circumstances. Choosing the optimal hospital
also may be based on factors such as patient travel times andrdiovascular Surgery c Volume 142, Number 3 e73
TABLE 2. Characteristics of hospital (N ¼ 102)
115.3 (70.8–168.1)
Hospital annual adult cardiac surgery
volume, median (25–75) n %
Public hospital 55 53.9
University hospital 46 45.1
General hospital 91 89.2
Recommended staffing and equipment* 65 63.7
Autologous blood transfusion system 88 86.3
Have an infection control team 90 88.2
Conference with cardiovascular surgeons
(every day)
49 48.0
Conference with cardiovascular surgeons
(1/wk)
99 97.1
Conference with cardiologists (every day) 7 6.9
Conference with cardiologists (1/wk) 74 72.5
Conference with nurse (1/wk) 47 46.1
Conference with anesthesiologist (1/wk) 40 39.2
Intensivists involved in postsurgical
management
54 52.9
Have some protocols regarding drug
selection
37 36.3
Have some protocols regarding drug dilution
method
70 68.6
Have some protocols regarding patients’
rehabilitation
49 48.0
Routinely check head and aortic wall CT scan 78 76.5
Preoperative beta-blocker use for CABG
surgery (first choice)
5 4.9
Discharge beta-blocker use for CABG
surgery (first choice)
12 11.8
Discharge antiplatelet use for CABG surgery
(first choice)
92 90.2
Discharge anti-lipid use for CABG surgery
(first choice)
15 14.7
ITA use for CABG surgery (first choice) 99 97.1
Off-pump procedure for CABG surgery
(first choice)
49 48.0
Surgeons do not have miscellaneous duties 59 57.8
Surgeons do not have>32-h labor 4 3.9
CT, Computed tomography; ITA, internal thoracic artery; CABG, coronary artery by-
pass grafting. *Recommended staffing and equipment were ‘‘>4 CV surgeons,’’ ‘‘>2
expert CV surgeons,’’ ‘‘>4 cardiologists,’’ ‘‘>2 anesthesiologists,’’ ‘‘>2 clinical en-
gineers,’’ ‘‘have an intensive-care unit facility,’’ ‘‘have a hemodialysis unit,’’ and
‘‘>2 heart-lung machines.’’
TABLE 3. Outcomes of each procedure (N ¼ 33,821)
Isolated CABG
surgery (N ¼ 10,972)
Valve su
(N ¼ 10
30-d operative mortality 2.2% 3.7
Composite mortality or major morbidity 14.2% 15.5
Reoperation for any reason 5.8% 6.8
Stroke 1.5% 1.8
Renal failure newly dialysis required 3.1% 3.6
Deep sternal infection 2.1% 1.5
Prolonged ventilation 5.8% 6.3
CABG, Coronary artery bypass grafting.
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Dinpatient service, as well as expected outcomes for each
hospital. In addition, cardiologists could use these models
to determine cardiovascular surgery indications, hospital
referral, and informed consent.
Effects of healthcare structures and processes in these
models have further implications. Previous studies revealed
the importance of teamwork in surgery as an important pre-
dictor of patient outcomes.17 Similarly, results of this study
suggest that interdisciplinary professional communication
may improve the outcome of cardiovascular surgery, al-
though the best style of communication may vary by coun-
try. Because more than 2 cardiovascular surgeons routinely
work together in cardiovascular surgery in Japan,7 97.1% of
participant hospitals have conferences with cardiovascular
surgeons more than once per week. These region-specific
characteristics might yield differences in the relative impact
of process and structure metrics between Japan and other
countries.
Although the effect of procedural volume reported by
previous studies7,8,18 implied a critical role for adequate
staffing and equipment, increased experience in high-
volume hospitals may also be important (‘‘practice makes
perfect’’ hypothesis). Meeting the recommended staffing
and equipment guidelines had significant effects on cardio-
vascular surgery outcomes (OR 0.75 in mortality model and
0.88 in composite model) independently of the hospital’s
annual adult cardiac surgery volume. The results of this
study also suggest that improving the work environment
of cardiovascular surgeons is important not only for sur-
geons but also for patients. Long, continuous labor is com-
mon in Japan. Although continuous labor more than 32
hours is banned by Japanese labor standards law, more
than 90% of hospitals routinely impose this on surgeons.
The lack of physician assistants in Japan means that sur-
geons have a wide range of work-related responsibilities.
Thus, most surgeons in this study report having miscella-
neous duties. The increased workload of doctors in Japa-
nese hospital means that many doctors experience work
burnout. A previous study indicated that hospitals operating
at or over capacity may experience heightened rates of ad-
verse events,19 and the present study also found that workrgery
,935)
Thoracic aortic surgery
(N ¼ 7559)
Other procedures
(N ¼ 4355)
All
procedures
% 8.4% 7.1% 4.7%
% 31.7% 19.5% 19.2%
% 9.3% 7.0% 7.1%
% 6.6% 2.5% 2.9%
% 6.1% 5.1% 4.2%
% 2.4% 1.7% 1.9%
% 19.2% 9.8% 9.5%
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TABLE 4. Description of each prediction model (N ¼ 27,191)
30-d operative mortality Composite mortality or major morbidity
P OR
95% CI
P OR
95% CI
Lower Upper Lower Upper
Preoperative risks
Age, y (1660, 61–65, 66–70, 71–75, 76–80, 81–100) .000 1.22 1.17 1.27 .000 1.11 1.09 1.13
BMI 31–35 kg/m2 .057 1.42 0.99 2.04 .000 1.76 1.49 2.08
BMI>35 kg/m2 .054 2.05 0.99 4.26 — — — —
Smoking — — — — .003 1.11 1.04 1.19
Diabetes — — — — .001 1.15 1.06 1.25
Renal failure .000 1.92 1.59 2.32 .000 2.19 1.95 2.45
Renal failure requiring dialysis .000 4.15 3.23 5.34 .080 2.53 2.15 2.98
Cerebrovascular disease (recent) — — — — .010 1.47 1.10 1.97
Infectious endocarditis .004 1.64 1.17 2.30 .006 1.36 1.09 1.69
COPD (moderate, severe) .000 2.49 1.87 3.30 .000 1.80 1.47 2.19
Extracardiac arteriopathy (peripheral) .000 1.61 1.35 1.92 .000 1.43 1.29 1.58
Extracardiac arteriopathy (thoracic) — — — — .000 1.28 1.14 1.43
Neurologic disorder .022 1.33 1.04 1.69 .002 1.29 1.10 1.51
Congestive heart failure .000 1.59 1.35 1.87 .000 1.27 1.17 1.39
Cardiogenic shock .000 1.68 1.35 2.10 .000 1.60 1.37 1.88
NYHA IV .000 1.51 1.24 1.84 .000 1.74 1.54 1.96
Preoperative inotropic agents .000 1.50 1.22 1.85 .000 1.34 1.16 1.55
Triple vessel disease — — — — .003 1.18 1.06 1.32
Poor LV function .000 2.34 1.90 2.87 .000 1.66 1.44 1.90
Tricuspid stenosis .030 2.63 1.10 6.31 .000 2.87 2.55 3.22
Reoperation .000 2.73 2.26 3.30 — — — —
Status (urgent) .000 1.72 1.39 2.13 .000 1.41 1.25 1.59
Status (emergency) .000 2.98 2.46 3.62 .000 2.06 1.81 2.33
Surgery type ‘‘isolated CABG’’ (reference) .000 .000
CABG combined surgery .000 1.65 1.38 1.98 .000 1.57 1.40 1.76
Surgery type ‘‘valve’’ .000 1.60 1.29 1.99 .001 1.26 1.10 1.43
Aortic valveþmitral valve .001 2.61 1.96 3.48 .000 1.85 1.58 2.18
Surgery type ‘‘thoracic aorta’’ .000 2.60 2.05 3.30 .000 1.61 1.35 1.92
Thoracic aortic surgery indication (rupture) .000 4.23 3.23 5.54 .000 2.58 2.08 3.19
Range of replacement (root) — — — — .082 1.93 1.57 2.36
Range of replacement (arch) .004 3.61 2.89 4.51 .000 2.52 2.22 2.87
Range of replacement (distal) .001 4.02 3.07 5.25 .004 2.04 1.74 2.40
Range of replacement (descending) .000 4.47 3.44 5.80 — — — —
Range of replacement (thoracoabdominal) .000 6.66 4.69 9.45 .000 3.34 2.66 4.20
Surgery type ‘‘other procedures’’ .000 2.16 1.71 2.72 .029 1.18 1.02 1.37
Resection/myoplasty .046 4.32 2.18 8.56 .025 1.99 1.26 3.13
Septal perforation/rupture — — — — .000 2.94 2.16 4.01
Structure and process of care
Hospital annual adult cardiac surgery volume (continuous) .000 0.998 0.997 0.999 0.000 0.999 0.998 0.999
Recommended staffing and equipment* .000 0.75 0.64 0.87 .003 0.88 0.80 0.95
Conference with cardiologists (every day) .073 0.79 0.60 1.02 — — — —
Conference with nurse (1/wk) — — — — .003 0.89 0.82 0.96
Intensivists concerned postsurgical management .090 0.89 0.77 1.02 .007 0.91 0.84 0.97
Have some protocols regarding drug dilution method — — — — .000 0.83 0.77 0.90
Public hospitals .003 0.80 0.70 0.93 — — — —
Surgeons do not have miscellaneous duties .003 0.80 0.70 0.93 .095 0.94 0.87 1.01
Surgeons do not have>32-h labor .032 0.55 0.32 0.95 — — — —
OR, Odds ratio; CI, confidence interval; BMI, body mass index; LV, left ventricle; NYHA, New York Heart Association; COPD, chronic obstructive pulmonary disease.
*Recommended staffing and equipment were ‘‘>4 CV surgeons,’’ ‘‘>2 expert CV surgeons,’’ ‘‘>4 cardiologists,’’ ‘‘>2 anesthesiologists,’’ ‘‘>2 clinical engineers,’’ ‘‘have an
intensive-care unit facility,’’ ‘‘have a hemodialysis unit,’’ and ‘‘>2 heart-lung machines.’’
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TABLE 5. Performance of each prediction model (N ¼ 6630)
30-d operative
mortality
Composite mortality or
major morbidity
C-statistics 0.847 0.744
Hosmer–Lemeshow test
(P value)
.790 .485
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Denvironment improvements might result in benefits for sur-
gery outcomes and surgeons’ quality of life.
Study Limitations
This study has several limitations. Although we chose
healthcare structures and processes of care based on inter-
views and previous studies, specific items we chose to rep-
resent the structures and processes may not cover all
relevant factors. For that reason, the validity of process
and structure metrics should be reevaluated. In addition,
process indicators were collected at the hospital level in
this study. To obtain a better understanding of process met-
rics relative to standardized clinical characteristics, future
studies should confirm process metrics at the patient level.
Because participation in the JACVSD is voluntary, the data-
base does not cover all cardiovascular programs in Japan.13
As such, the generalizability of our findings is limited. In
addition, although predicted patient outcomes based on hos-
pital process compliance rates may be useful for choosing
a hospital, patients do not always have sufficient granularity
information, such as whether the appropriate processes are
in place or whether the surgical skill for a particular proce-
dure they require is available. Patients should be cautious in
their search, recognizing that individual circumstances may
dictate different requirements.
CONCLUSIONS
To better understand the volume–outcome relationship in
cardiovascular surgery, we focused on practices that involve
cardiovascular procedures, including hospital processes and
structure, which embody potential risks of perioperative
mortality. Our models yielded good discrimination and cal-
ibration, so they may prove useful for hospital selection
based on individual patient risks and circumstances. As
for structure of care in Japan, improved surgeon work envi-
ronments were also shown to be important for both surgeons
and patients.e76 The Journal of Thoracic and Cardiovascular SurgThe authors thank all data managers and hospitals that partici-
pated in the JACVSD project for their efforts in data entry.
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